On the fly News and insights, exclusive to thefly.com

ZM

Zoom Video

$91.83 /

+0.41 (+0.45%)

, WORK

Slack Technologies

$34.27 /

-0.73 (-2.09%)

10:14
07/12/19
07/12
10:14
07/12/19
10:14

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Slack Technologies (WORK) and Zoom Video (ZM) were initiated with an Overweight at Stephens. 2. Fate Therapeutics (FATE) initiated with an Outperform at Oppenheimer. 3. Ameris Bancorp (ABCB) initiated with an Outperform at Raymond James. 4. TriCo Bancshares (TCBK) initiated with a Neutral at Piper Jaffray. 5. Axalta Coating (AXTA) initiated with a Buy at Berenberg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ZM

Zoom Video

$91.83 /

+0.41 (+0.45%)

WORK

Slack Technologies

$34.27 /

-0.73 (-2.09%)

FATE

Fate Therapeutics

$21.45 /

+1.05 (+5.15%)

ABCB

Ameris Bancorp

$38.74 /

+0.17 (+0.44%)

TCBK

TriCo Bancshares

$38.52 /

+0.41 (+1.08%)

AXTA

Axalta Coating

$29.40 /

+0.01 (+0.03%)

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 09

    Sep

  • 23

    Sep

ZM Zoom Video
$91.83 /

+0.41 (+0.45%)

07/12/19 William Blair
Zoom Video growth still in 'early innings,' says William Blair
07/11/19 Stephens
Zoom Video initiated with an Overweight at Stephens
07/01/19
Fly Intel: Top five analyst downgrades
07/01/19 Goldman Sachs
Zoom Video downgraded to Sell from Neutral at Goldman Sachs
WORK Slack Technologies
$34.27 /

-0.73 (-2.09%)

07/11/19 Stephens
Slack Technologies initiated with an Overweight at Stephens
07/09/19
Fly Intel: Top five analyst initiations
07/09/19
Slack Technologies initiated with a Perform on valuation at Oppenheimer
07/08/19 Oppenheimer
Slack Technologies initiated with a Perform at Oppenheimer
FATE Fate Therapeutics
$21.45 /

+1.05 (+5.15%)

07/12/19 Oppenheimer
Fate's iPSC technology could disrupt cancer cell therapy field, says Oppenheimer
07/11/19 Oppenheimer
Fate Therapeutics initiated with an Outperform at Oppenheimer
06/27/19 Piper Sandler
Fate Therapeutics price target raised to $30 from $23 at Piper Jaffray
06/27/19 Piper Sandler
Piper keeps Crispr, Fate as top picks for 2019, adds Arvinas
ABCB Ameris Bancorp
$38.74 /

+0.17 (+0.44%)

07/11/19 Raymond James
Ameris Bancorp initiated with an Outperform at Raymond James
05/15/19 Stephens
Stephens replaces CenterState with Ameris as 2019 Best Idea
01/29/19 SunTrust
Ameris Bancorp upgraded to Buy from Hold at SunTrust
01/29/19 SunTrust
Ameris Bancorp upgraded to Buy from Hold at SunTrust
TCBK TriCo Bancshares
$38.52 /

+0.41 (+1.08%)

07/12/19 Piper Sandler
TriCo Bancshares initiated with a Neutral at Piper Jaffray
07/09/19 Stephens
TriCo Bancshares downgraded to Equal Weight from Overweight at Stephens
AXTA Axalta Coating
$29.40 /

+0.01 (+0.03%)

07/12/19 Berenberg
Axalta Coating initiated with a Buy at Berenberg
06/26/19 KeyBanc
Axalta Coating price target raised to $35 from $30 at KeyBanc
06/21/19 BMO Capital
Axalta Coating price target raised to $34 from $32 at BMO Capital
06/20/19 Deutsche Bank
Axalta sale in mid-$30s per share most likely outcome, says Deutsche Bank

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.